ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Application of machine learning to identify risk factors for bloodstream infections caused by different antimicrobial resistance phenotypes in chemotherapy patients.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBloodstream infections (BSIs) remain a major cause of morbidity and mortality in patients undergoing chemotherapy. The rising incidence of multidrug-resistant organisms (MDROs) further challenges the adequacy of empirical antimicrobial therapy. Therefore, this study aimed to identify features associated with different microbiological profiles of BSIs in chemotherapy patients using machine learning models.
methodsWe retrospectively analyzed 1435 confirmed BSI episodes among 1220 patients treated at a tertiary cancer center from 2017 to 2022. A multi-label classification approach was used to model BSIs associated with carbapenem-resistant Gram-negative bacilli (CR-GNB), methicillin-resistant staphylococci, third-generation cephalosporin-resistant Enterobacterales (3GCRE), fungal pathogens, and non-MDRO/non-fungal. Classifier chain models based on logistic regression, random forests, neural networks, and gradient boosting were trained and evaluated using cross-validation with an independent test set. Model outputs were interpreted using SHapley Additive exPlanations (SHAP) to estimate feature contributions.
resultsMost BSIs occurred during the first chemotherapy cycle and were due to non-MDROs or fungal agents (1193 episodes; 83.1%), CR-GNB was identified in 109 (7.6%). Model performance varied across pathogen groups, with the highest discrimination observed for CR-GNB (AUC-ROC 83.25%; 95% CI 73.91%-91.64%). Key features included hospitalization days, hematologic malignancy, prior MDRO infection, monocytopenia, and palliative chemotherapy. Chemotherapy class contributed differently across pathogen groups, with alkylating agents contributing to candidemia, antitumor antibiotics to CR-GNB, and antimetabolites to 3GCRE. Prior CR-GNB infection was the strongest predictor for CR-GNB BSI, while palliative chemotherapy correlated with non-MDRO/non-fungal BSI.
conclusionMulti-label machine learning approaches may help disentangle the complex etiologies of BSIs in cancer patients by identifying associations between host factors, prior MDRO infection, and chemotherapy class within confirmed BSI episodes, informing future hypothesis generation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.